Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV–ACS
Open Access
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 147 (5) , 865-873
- https://doi.org/10.1016/j.ahj.2003.11.009
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes.Published by Oxford University Press (OUP) ,2002
- Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsThe Lancet, 2002
- Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 2001
- Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes: Gusto IV-ACSThe Lancet, 2001
- Unstable Angina PectorisNew England Journal of Medicine, 2000
- Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularizationAmerican Heart Journal, 1999
- The challenge of acute coronary syndromesThe Lancet, 1999
- Platelet glycoprotein IIB/IIA receptor antagonists An asset for treatment of unstable coronary syndromes and coronary interventionPublished by Oxford University Press (OUP) ,1998
- Aspirin, the poor man's statin?The Lancet, 1998
- Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial InfarctionNew England Journal of Medicine, 1997